--- title: "NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuit" type: "News" locale: "en" url: "https://longbridge.com/en/news/292640281.md" description: "The Shareholders Foundation announces a pending securities class action lawsuit against PACS Group, Inc., alleging false Medicare claims and misleading statements from 2020-2023. Investors who bought shares prior to April 2024 are urged to contact the Foundation for potential legal options." datetime: "2026-07-14T14:05:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292640281.md) - [en](https://longbridge.com/en/news/292640281.md) - [zh-HK](https://longbridge.com/zh-HK/news/292640281.md) --- # NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuit SAN DIEGO, July 14, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit is currently pending for certain investors in PACS Group, Inc. () shares. NOTICE: Investors who purchased shares of PACS Group, Inc. () prior to April 2024 and continue to hold any of those shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On November 13, 2024, a investor in shares filed a lawsuit against PACS Group, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants failed to disclose to investors that the Company engaged in a "scheme" to submit false Medicare claims which "drove more than 100% of PACS' operating and net income from 2020 – 2023", that the Company engaged in a "scheme" to "bill thousands of unnecessary respiratory and sensory integration therapies to Medicare", that the Company engaged in a scheme to falsify documentation related to licensure and staffing, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On December 19, 2025, a consolidated amended complaint was filed and on February 17, 2026, the defendants filed their motion to dismiss the case. Those who purchased shares of PACS Group, Inc. () should contact the Shareholders Foundation, Inc. CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108 The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon. SOURCE Shareholders Foundation, Inc. ### Related Stocks - [PACS.US](https://longbridge.com/en/quote/PACS.US.md) ## Related News & Research - [PACS Group, Inc. $PACS Shares Purchased by Sei Investments Co.](https://longbridge.com/en/news/294578963.md) - [PACS Group (NYSE:PACS) Shares Up 4.2% - Here's Why](https://longbridge.com/en/news/293778092.md) - [Huntington Ingalls declares quarterly dividend of $1.38 per share](https://longbridge.com/en/news/294213498.md) - [03:58 ETADMA Biologics, Inc. Investor Alert: Contact SBS by August 10, 2026 for Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/294029671.md) - [Howmet Aerospace Inc. (NYSE:HWM) Declares Quarterly Dividend of $0.14](https://longbridge.com/en/news/294055354.md)